• Molecular NameAceprometazine
  • Synonym10-(2-(Dimethylamino)propyl)phenothiazin-2-yl methyl ketone; Aceprometazina [inn-spanish]; Aceprometazinum [inn-latin]; Acepromethazine
  • Weight326.464
  • Drugbank_IDDB01615
  • ACS_NO13461-01-3
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)4.46
  • pkaN/A
  • LogD (pH=7, predicted)2.73
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-3.14
  • LogSw (predicted, AB/LogsW2.0)0.01
  • Sw (mg/ml) (predicted, ACD/Labs)0.01
  • No.of HBond Donors0
  • No.of HBond Acceptors3
  • No.of Rotatable Bonds4
  • TPSA48.85
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA phenothiazine derivative prescription drug with neuroleptic and anti-histamine properties.
  • Absorption_valueN/A
  • Absorption (description)Rapidly absorbed following oral administration
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmHepatic
  • Half lifeN/A
  • ExcretionRenal and fecal
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A